Lilly Ventures Fund I LLC
Insider CIK 1575852 · PTGX 10% owner · CERU 10% owner · ALRN · RCPT 10% owner · CHRS · AGLE 10% owner · SURF 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SURF Surface Oncology, Inc. | C Conversion deriv | 2018-04-23 | 2018-04-23 | 7,000,000 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | P Buy | 2018-04-23 | 2018-04-23 | 266,000 | $15.00 | $3.99M | 3,447,817 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion | 2018-04-23 | 2018-04-23 | 3,181,817 | — | $0 | 3,181,817 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-07 | 1,654,411 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-07 | 1,443,972 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-07 | 1,907,373 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-07 | 3,390,885 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | P Buy | 2017-07-05 | 2017-07-07 | 250,000 | $15.00 | $3.75M | 1,094,987 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion | 2017-07-05 | 2017-07-07 | 844,987 | — | $0 | 844,987 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion deriv | 2016-08-16 | 2016-08-16 | 3,000,000 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion deriv | 2016-08-16 | 2016-08-16 | 9,142,857 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion deriv | 2016-08-16 | 2016-08-16 | 9,841,333 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion | 2016-08-16 | 2016-08-16 | 630,541 | — | $0 | 837,437 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion | 2016-08-16 | 2016-08-16 | 206,896 | — | $0 | 206,896 | SEC↗ |
| PTGX Protagonist Therapeutics, | P Buy | 2016-08-16 | 2016-08-16 | 583,333 | $12.00 | $7.00M | 2,099,482 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion | 2016-08-16 | 2016-08-16 | 678,712 | — | $0 | 1,516,149 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | C Conversion | 2016-04-12 | 2016-04-14 | 2,010,924 | — | $0 | 2,068,543 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion deriv | 2014-11-12 | 2014-11-12 | 2,333,955 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion deriv | 2014-11-12 | 2014-11-12 | 543,101 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion | 2014-11-12 | 2014-11-12 | 2,333,955 | — | $0 | 2,333,955 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | P Buy | 2014-11-12 | 2014-11-12 | 164,963 | $13.50 | $2.23M | 3,042,019 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion | 2014-11-12 | 2014-11-12 | 543,101 | — | $0 | 2,877,056 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 13,513,513 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 0 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 0 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 4,340,831 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 192,209 | — | $0 | 1,422,907 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 299,213 | — | $0 | 1,230,698 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 199,875 | — | $0 | 1,622,782 | SEC↗ |
| CERU Cerulean Pharma Inc. | P Buy | 2014-04-15 | 2014-04-15 | 733,445 | $7.00 | $5.13M | 2,356,227 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 931,485 | — | $0 | 931,485 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-11-21 | 0 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-11-21 | 0 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | P Buy | 2013-05-14 | 2013-11-21 | 142,857 | $14.00 | $2.00M | 2,081,210 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-11-21 | 1,152,039 | $5.25 | $6.05M | 1,266,324 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-11-21 | 672,029 | $7.73 | $5.19M | 1,938,353 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-05-14 | 5,040,221 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-05-14 | 8,640,289 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-05-14 | 672,029 | $7.73 | $5.19M | 1,938,353 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-05-14 | 1,152,039 | $5.25 | $6.05M | 1,266,324 | SEC↗ |
| RCPT Receptos, Inc. | P Buy | 2013-05-14 | 2013-05-14 | 142,857 | $14.00 | $2.00M | 2,081,210 | SEC↗ |